Flagship Ventures Fund IV-RX, LP

Track

Insider profile

Flagship Ventures Fund IV-RX, LP's trades of Syros Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
322.16
Quantity 77,400
Value US$1,707,093
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-13 2024-12-13
PrS Proposed sale
77,400
322.16
US$1,707,093 		77,400 322.16 US$1,707,093